2039 related articles for article (PubMed ID: 12958144)
1. Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors.
Yamakawa M; Liu LX; Date T; Belanger AJ; Vincent KA; Akita GY; Kuriyama T; Cheng SH; Gregory RJ; Jiang C
Circ Res; 2003 Oct; 93(7):664-73. PubMed ID: 12958144
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1.
Liu LX; Lu H; Luo Y; Date T; Belanger AJ; Vincent KA; Akita GY; Goldberg M; Cheng SH; Gregory RJ; Jiang C
Biochem Biophys Res Commun; 2002 Mar; 291(4):908-14. PubMed ID: 11866451
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the angiogenesis response through Ha-ras control, placenta growth factor, and angiopoietin expression in mouse skin carcinogenesis.
Larcher F; Franco M; Bolontrade M; Rodriguez-Puebla M; Casanova L; Navarro M; Yancopoulos G; Jorcano JL; Conti CJ
Mol Carcinog; 2003 Jun; 37(2):83-90. PubMed ID: 12766907
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
5. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
Koyama S; Takagi H; Otani A; Oh H; Nishimura K; Honda Y
Br J Pharmacol; 2002 Nov; 137(6):901-9. PubMed ID: 12411422
[TBL] [Abstract][Full Text] [Related]
7. Early expression of angiogenesis factors in acute myocardial ischemia and infarction.
Lee SH; Wolf PL; Escudero R; Deutsch R; Jamieson SW; Thistlethwaite PA
N Engl J Med; 2000 Mar; 342(9):626-33. PubMed ID: 10699162
[TBL] [Abstract][Full Text] [Related]
8. von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis.
Jones MK; Szabó IL; Kawanaka H; Husain SS; Tarnawski AS
FASEB J; 2002 Feb; 16(2):264-6. PubMed ID: 11772947
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.
Kelly BD; Hackett SF; Hirota K; Oshima Y; Cai Z; Berg-Dixon S; Rowan A; Yan Z; Campochiaro PA; Semenza GL
Circ Res; 2003 Nov; 93(11):1074-81. PubMed ID: 14576200
[TBL] [Abstract][Full Text] [Related]
10. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L
J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990
[TBL] [Abstract][Full Text] [Related]
11. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
12. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
13. Endothelial PAS domain protein 1 gene promotes angiogenesis through the transactivation of both vascular endothelial growth factor and its receptor, Flt-1.
Takeda N; Maemura K; Imai Y; Harada T; Kawanami D; Nojiri T; Manabe I; Nagai R
Circ Res; 2004 Jul; 95(2):146-53. PubMed ID: 15192019
[TBL] [Abstract][Full Text] [Related]
14. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.
Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL
Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908
[TBL] [Abstract][Full Text] [Related]
15. Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury.
Date T; Mochizuki S; Belanger AJ; Yamakawa M; Luo Z; Vincent KA; Cheng SH; Gregory RJ; Jiang C
Am J Physiol Cell Physiol; 2005 Feb; 288(2):C314-20. PubMed ID: 15496478
[TBL] [Abstract][Full Text] [Related]
16. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
[TBL] [Abstract][Full Text] [Related]
17. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
18. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha.
Elson DA; Thurston G; Huang LE; Ginzinger DG; McDonald DM; Johnson RS; Arbeit JM
Genes Dev; 2001 Oct; 15(19):2520-32. PubMed ID: 11581158
[TBL] [Abstract][Full Text] [Related]
19. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
[TBL] [Abstract][Full Text] [Related]
20. Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death.
Kotch LE; Iyer NV; Laughner E; Semenza GL
Dev Biol; 1999 May; 209(2):254-67. PubMed ID: 10328919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
